Literature DB >> 1971400

Thalidomide in hyperalgic pharyngeal ulceration of AIDS.

I Gorin, B Vilette, P Gehanno, J P Escande.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1971400     DOI： 10.1016/0140-6736(90)91223-w

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain.

Authors:  Mariana L Vale; Verônica M Benevides; Daniela Sachs; Gerly A C Brito; Francisco A C da Rocha; Stephen Poole; Sérgio H Ferreira; Fernando Q Cunha; Ronaldo A Ribeiro
Journal:  Br J Pharmacol       Date:  2004-11-01       Impact factor: 8.739

Review 2.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

3.  Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene.

Authors:  D Tsambaos; K Bolsen; S Georgiou; A Monastirli; G Goerz
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

4.  Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.

Authors:  R Neubert; A C Nogueira; D Neubert
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

5.  Thalidomide: an emerging drug in oral mucosal lesions.

Authors:  K Mubeen; M Ahmed Siddiq; V R Jigna
Journal:  Clin J Gastroenterol       Date:  2009-06-02

6.  Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.

Authors:  E P Sampaio; A L Moreira; E N Sarno; A M Malta; G Kaplan
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.